todayonchain.com

Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now

BeInCrypto
Goldman Sachs says big pharma is sourcing drug assets from China biotech as patents expire.

Summary

Full summary available to members

Subscribe to TodayOnChain membership to read full news summaries and browse without display ads.